• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
FDA
Favicon Fierce Pharma

FDA taps George Tidmarsh to lead CDER

George Tidmarsh, M.D., Ph.D., will head up the FDA's Center for Drug Evaluation and Research after a lengthy career in academia and biopharma.
Zoey Becker Jul 21, 2025 10:53am
FDA Pathways Offer Faster Track for Oncology Drug Development
Sponsored

FDA Pathways Offer Faster Track for Oncology Drug Development

Jul 21, 2025 8:00am
Sarepta Sarepta Therapeutics
Favicon Fierce Pharma

Sarepta will continue shipping Elevidys despite FDA misgivings

Jul 21, 2025 10:42am
Pac man eat MA deal buy sell merger

iTeos, reeling from TIGIT fail, is latest prize for Concentra

Jul 21, 2025 9:36am
Graphic images of two workers with wind up backs one of which is awake and active and the other is asleep

Chasing Takeda, Alkermes reports phase 2 narcolepsy win

Jul 21, 2025 8:40am
money funding financing bank

Omega raises $647M for 8th fund aimed at innovative biotechs

Jul 21, 2025 8:15am
More News

Berkeley incubator plots new building for expanding biotechs

Jul 21, 2025 8:00am

Roche's COPD drug flunks ph. 3, denting hopes of 2025 approval

Jul 21, 2025 4:38am

Cloudbreak plots phase 3 after eye drop passes midstage test

Jul 21, 2025 4:35am

Hookipa, having sold off vaccines to Gilead, opts to wind down

Jul 21, 2025 3:15am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings